The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the T
RNA sequencing
TH17 cells
gene set enrichment analysis
glioblastoma multiforme
tissue residency
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
23 08 2022
23 08 2022
Historique:
entrez:
15
8
2022
pubmed:
16
8
2022
medline:
18
8
2022
Statut:
ppublish
Résumé
Although glioblastoma multiforme (GBM) is not an invariably cold tumor, checkpoint inhibition has largely failed in GBM. In order to investigate T cell-intrinsic properties that contribute to the resistance of GBM to endogenous or therapeutically enhanced adaptive immune responses, we sorted CD4
Identifiants
pubmed: 35969754
doi: 10.1073/pnas.2206208119
pmc: PMC9407554
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2206208119Références
Nat Immunol. 2017 Aug;18(8):940-950
pubmed: 28628092
Blood. 2003 Apr 1;101(7):2620-7
pubmed: 12411307
Nat Rev Cancer. 2021 Dec;21(12):786-802
pubmed: 34584243
Nat Immunol. 2018 Oct;19(10):1126-1136
pubmed: 30201991
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Annu Rev Immunol. 2009;27:485-517
pubmed: 19132915
Nature. 2008 May 1;453(7191):106-9
pubmed: 18362914
Nat Immunol. 2007 Jun;8(6):639-46
pubmed: 17486092
Nat Commun. 2018 Feb 8;9(1):559
pubmed: 29422647
J Immunother Cancer. 2020 Oct;8(2):
pubmed: 33093158
Br J Cancer. 2014 May 13;110(10):2560-8
pubmed: 24691423
Nat Immunol. 2017 Jan;18(1):74-85
pubmed: 27893700
Cell. 2015 May 21;161(5):1202-1214
pubmed: 26000488
Clin Cancer Res. 2018 Sep 1;24(17):4175-4186
pubmed: 29437767
Nat Immunol. 2019 Sep;20(9):1100-1109
pubmed: 31358997
Immunity. 2012 Jul 27;37(1):134-46
pubmed: 22683122
Annu Rev Immunol. 2019 Apr 26;37:457-495
pubmed: 30676822
J Exp Med. 2009 Jul 6;206(7):1457-64
pubmed: 19564351
Science. 2015 Jan 23;347(6220):400-6
pubmed: 25477212
Cell. 2017 Sep 7;170(6):1120-1133.e17
pubmed: 28803728
Nature. 2008 May 1;453(7191):65-71
pubmed: 18362915
Nature. 2011 Oct 05;478(7368):197-203
pubmed: 21976023
Oncotarget. 2019 May 3;10(33):3129-3143
pubmed: 31139325
Comput Struct Biotechnol J. 2021 Jun 30;19:3796-3798
pubmed: 34285779
Proc Natl Acad Sci U S A. 2022 Aug 23;119(34):e2206208119
pubmed: 35969754
J Transl Med. 2019 Mar 20;17(1):96
pubmed: 30894200
Bioinformatics. 2019 Jun 1;35(12):2084-2092
pubmed: 30395178
Oncoimmunology. 2015 Jul 6;5(1):e1055444
pubmed: 26942062
Nature. 2021 Apr;592(7854):463-468
pubmed: 33762734
Cytokine. 2021 Oct;146:155654
pubmed: 34325116
J Immunother Cancer. 2021 Jan;9(1):
pubmed: 33462141
Sci Rep. 2018 Jul 19;8(1):10954
pubmed: 30026493
Cell. 2013 Oct 10;155(2):462-77
pubmed: 24120142
Sci Rep. 2016 May 09;6:25533
pubmed: 27156886
Cell. 2020 Jun 25;181(7):1643-1660.e17
pubmed: 32470396
Nat Genet. 2003 Jul;34(3):267-73
pubmed: 12808457
Front Immunol. 2018 May 17;9:1072
pubmed: 29868026
Cell. 2013 Mar 28;153(1):139-52
pubmed: 23540695
Cell. 2019 Aug 8;178(4):835-849.e21
pubmed: 31327527
Neuropathol Appl Neurobiol. 2018 Feb;44(2):185-206
pubmed: 28767130
Nat Rev Immunol. 2010 Apr;10(4):248-56
pubmed: 20336152
Nat Neurosci. 2019 May;22(5):729-740
pubmed: 30962630
Front Bioeng Biotechnol. 2020 Jun 30;8:592
pubmed: 32695752
Cell. 2020 Jun 25;181(7):1626-1642.e20
pubmed: 32470397
J Immunother Cancer. 2021 Jun;9(6):
pubmed: 34083422
Lancet Oncol. 2016 Jul;17(7):976-983
pubmed: 27267608
Nat Med. 2019 Mar;25(3):462-469
pubmed: 30742119
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Nature. 2010 Oct 21;467(7318):967-71
pubmed: 20962846